It is currently Mon Sep 25, 2017 11:57 am

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Redhill announces Phase IIa trial data

RedHill Biopharma has announced “encouraging” top-line interim results from its CEASE-MS Phase IIa proof-of-concept (PoC) clinical study evaluating fixed oral doses of RHB-104 in patients treated for relapsing-remitting multiple sclerosis (RRMS)....Read more - http://www.ms-uk.org/MSnews
Read more : Redhill announces Phase IIa trial data | Views : 1367 | Replies : 3




baclofen

Does anyone take a low dose of baclofen? I wake up and I'm stiff as a board.
Read more : baclofen | Views : 1386 | Replies : 5




The Latest Innovations in the Drug Pipeline for MS

A review of investigational drugs in ongoing Phase 3 studies:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684635/
Read more : The Latest Innovations in the Drug Pipeline for MS | Views : 1602 | Replies : 0


Potential new therapeutic for Relapsing MS patients

RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulators for relapsing multiple sclerosis (MS) patients results showed significant reductions in the cumulative number of total gadolinium-enhancing (GdE) lesions...Read more - http://www.ms-uk.org/MSnews
Read more : Potential new therapeutic for Relapsing MS patients | Views : 1645 | Replies : 0










 

Login  •  Register


Statistics

Total posts 239732 • Total topics 26176 • Total members 17436


Contact us | Terms of Service